|
DDX18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.19639853579656E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.43340003702741E-09 |
| Normal-vs-Stage2 |
1.26119999999119E-07 |
| Normal-vs-Stage3 |
1.29000032877968E-10 |
| Normal-vs-Stage4 |
1.12440057264962E-11 |
| Stage1-vs-Stage2 |
2.498800E-01 |
| Stage1-vs-Stage3 |
1.400640E-01 |
| Stage1-vs-Stage4 |
1.100290E-02 |
| Stage2-vs-Stage3 |
9.381800E-01 |
| Stage2-vs-Stage4 |
4.955400E-01 |
| Stage3-vs-Stage4 |
3.152000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.99165161929704E-12 |
| Normal-vs-AfricanAmerican |
1.360570E-03 |
| Normal-vs-Asian |
3.8849000000285E-06 |
| Caucasian-vs-AfricanAmerican |
3.401800E-01 |
| Caucasian-vs-Asian |
5.915600E-01 |
| AfricanAmerican-vs-Asian |
6.703000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.53754828050523E-12 |
| Normal-vs-Female |
3.06830005847303E-10 |
| Male-vs-Female |
1.565040E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.50170000271055E-08 |
| Normal-vs-Age(41-60Yrs) |
1.07829967177508E-10 |
| Normal-vs-Age(61-80Yrs) |
1.19810050769331E-10 |
| Normal-vs-Age(81-100Yrs) |
1.533970E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.006600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.932400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.380400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.268400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.391400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.887400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.868300E-02 |
| Classical-VS-Follicular |
2.296600E-03 |
| Classical-VS-Other |
1.143150E-01 |
| Classical-VS-Normal |
1.07530000459377E-08 |
| Tall-VS-Follicular |
9.406200E-01 |
| Tall-VS-Other |
5.307200E-01 |
| Tall-VS-Normal |
4.66049999703344E-08 |
| Follicular-VS-Other |
6.404600E-01 |
| Follicular-VS-Normal |
3.43269968006155E-10 |
| Other-VS-Normal |
3.166800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.29779537011632E-11 |
| Normal-vs-N1 |
6.66269994731294E-09 |
| N0-vs-N1 |
7.070600E-01 |
|
|
